
Tali Czarnowicki, MD
About Me
Tali Czarnowicki, MD, is Director of Outpatient Dermatology at Mount Sinai Queens and an Associate Professor of Dermatology at the Icahn School of Medicine at Mount Sinai. She earned her medical degree with honors from the Technion—Israel Institute of Technology before completing a residency in dermatology at the Hadassah Medical Center in Jerusalem. Dr. Czarnowicki was then appointed an attending associate physician at Rockefeller University in New York City, where she conducted research in investigative dermatology and earned a Master’s degree in Medical Sciences.
Dr. Czarnowicki is passionate about researching and treating inflammatory skin diseases like eczema, psoriasis, vitiligo, and alopecia—combining dermatology research with practice to discover underlying skin diseases and optimize patient care. She believes that successfully treating these can dramatically improve quality of life among her patients, and she takes special care to listen to their concerns and explain their care in plain language. Dr. Czarnowicki is closely involved in taking lessons learned in medical research and transferring these to applications into patient care. She is widely published, including numerous studies on eczema and psoriasis.
Language
English
Position
ADJUNCT ASSOCIATE PROFESSOR | Dermatology
Education
MSc, Rockefeller University
Residency, Hadassah-Hebrew University Medical Center
Awards
2014
Kligman Travel Fellowship
Society of Investigative Dermatology
2010
John Stratigos Memorial Scholarship
European Academy of Dermatology & Venereology
Research
Publications
Selected Publications
- Divergent Paths: A Comprehensive Review of Mechanisms and Clinical Implications in Atopic Dermatitis and Psoriasis. Tali Czarnowicki, Kazunari Sugita, Zenas Yiu, Sandra Díez-Ribas, Irene Garcia-Jimenez, Emma Guttman-Yassky, Luis F. Santamaria-Babí. Allergy: European Journal of Allergy and Clinical Immunology
- Crisaborole 2% for Pediatric Periorificial Dermatitis: A Randomized, Double-Blind, Vehicle-Controlled Pilot Study. Ayelet Ollech, Bat El Bar Aluma, Adi Weiss-Fink, Amir Horev, Ori Toker, Tali Czarnowicki. Annals of Dermatology
- Effectiveness, Quality of Life and Durability of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Real-World Evidence from the PRIMMA Study. Igor Snast, Yuliya Valdman-Grinshpoun, Naji Bathish, Hagit Matz, Yuri Shclar, Sari Murad, Tali Czarnowicki, Eran Shavit, Liuqing Yang, Sandra Goss, Inbal Piller Maor, Assaf Halperin, Shiran Naftalberg Blonder, Raanan Cohen, Alex Bleterman, Moran Barak, Lev Pavlovsky. Dermatology and Therapy
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Czarnowicki has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.